10.6084/m9.figshare.5477911.v1
Asano M.
Asano
M.
Thumma J.
Thumma
J.
Oguchi K.
Oguchi
K.
Pisoni R.L.
Pisoni
R.L.
Akizawa T.
Akizawa
T.
Akiba T.
Akiba
T.
Fukuhara S.
Fukuhara
S.
Kurokawa K.
Kurokawa
K.
Ethier J.
Ethier
J.
Saran R.
Saran
R.
Saito A.
Saito
A.
for the J-DOPPS Research Group
for the J-DOPPS Research
Group
Supplementary Material for: Vascular Access Care and Treatment Practices Associated with Outcomes of Arteriovenous Fistula: International Comparisons from the Dialysis Outcomes and Practice Patterns Study
Karger Publishers
2017
Arteriovenous fistula ·
Hemodialysis ·
Vascular access
Fistula patency
2017-10-06 11:21:51
Journal contribution
https://karger.figshare.com/articles/journal_contribution/Supplementary_Material_for_Vascular_Access_Care_and_Treatment_Practices_Associated_with_Outcomes_of_Arteriovenous_Fistula_International_Comparisons_from_the_Dialysis_Outcomes_and_Practice_Patterns_Study/5477911
<p><b><i>Background:</i></b> Vascular access (VA) guidelines recommend
the native arteriovenous fistula (AVF) as VA of first choice for chronic
hemodialysis patients. AVF management is important in hemodialysis
patient care. AVF survival is associated with various physical factors,
but the effects of dialysis treatment factors upon AVF survival are
still not clear. <b><i>Methods:</i></b> Study patients were treated at
498 dialysis facilities participating in the Dialysis Outcomes and
Practice Patterns Study (DOPPS) 2 or 3 (2002-2007). Analyses included
1,183 incident hemodialysis patients (on dialysis ≤7 days and using an
AVF at study entry) and 949 prevalent patients (on dialysis >7 days
at DOPPS entry and using a new AVF created during study observation).
AVF survival was modeled from the study entry date for incident patients
and date of first AVF use for prevalent patients. Predictors of primary
and final AVF survival were compared across Japan, North America and
Europe/Australia/New Zealand (EUR/ANZ) with adjustments for patient
characteristics. <b><i>Results:</i></b> No meaningful relationship was
seen between AVF survival and various physician and staff practices.
However, patients with prior catheter use displayed higher rates of
primary and final AVF failure. Final AVF failure rates were higher in
facilities with higher median blood flow rates (BFR). They were also
greater in North America and EUR/ANZ than in Japan, but this difference
was substantially attenuated after accounting for regional differences
in facility median BFR. <b><i>Conclusion:</i></b> AVF longevity differed
according to the DOPPS region, and was related to prior patient
catheter use and facility BFR practice. Further longitudinal studies may
help demonstrate meaningful associations between VA-handling skill and
patency.</p>